In AcouSort’s pipeline is AcouPlasma, the first example of the company’s long-term strategy to provide OEM components and modules for life science analytical and diagnostic systems. The blood-plasma separation module will enable analysis of blood plasma from whole blood samples, eliminating the need for previous centrifugation.
AcouSort has several ongoing or starting collaboration projects for this OEM product with international life science partners representing separate application areas. To separate plasma from blood cells in whole blood samples is the first step for a large number of clinical chemistry methods, where our OEM module could replace centrifugation, facilitating automation and miniaturization. AcouSort has conducted feasibility development studies proving the functionality of the planned separation modules both for chemical and optical plasma analyses. Thus, the development of the first actual OEM product is in the development phase together with an external partner with the prospect of initially providing 100,000+ OEM modules per year. At the same time, AcouSort is searching for additional partners within other fields of application for blood-plasma separation modules.